Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of triple, sequential, and concomitant quadruple therapy for Helicobacter pylori in Korea
KCT0000703Phase 2Not yet recruiting
- Sponsor
- The Catholic University of Korea
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amoxicillin, clarithromycin, metronidazole, bismuth subsalicylate in Helicobacter pylori infection, Peptic ulcer disease (PUD), gastric cancer (GC), marginal zone B-cell lymphoma (MZL), sponsored by The Catholic University of Korea. Planned start Apr 2013; status: not yet recruiting.
02
Drugs
amoxicillinclarithromycinmetronidazolebismuth subsalicylate
03
Conditions
Helicobacter pylori infectionPeptic ulcer disease (PUD)gastric cancer (GC)marginal zone B-cell lymphoma (MZL)
Beyond the preview
Go deeper on KCT0000703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000703.